Interventions for reducing inflammation in familial Mediterranean fever

Cochrane Collaboration

Cochrane Database Syst Rev · 2022

Grade Asystematic review

Key Findings

  • 10 RCTs with 312 participants
  • Colchicine may reduce people experiencing attacks
  • Includes assessment of rilonacept, anakinra, canakinumab

Referenced in (1 disease)

ID: pmid-35349164PMID: 35349164